These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Factor V Leiden G1691A, Prothrombin G20210A, and MTHFR C677T and A1298C Mutations in Patients With Sickle Cell Disease in Tunisia. Belhaj Nefissi R; Doggui R; Ouali F; Messaoud T; Gritli N Hemoglobin; 2018 Mar; 42(2):96-102. PubMed ID: 30200836 [TBL] [Abstract][Full Text] [Related]
4. Premarital screening test results for β-thalassemia and sickle cell anemia trait in east Mediterranean region of Turkey. Guler E; Garipardic M; Dalkiran T; Davutoglu M Pediatr Hematol Oncol; 2010 Nov; 27(8):608-13. PubMed ID: 20795773 [TBL] [Abstract][Full Text] [Related]
5. Prevalence of factor V Leiden G1691A, MTHFR C677T, and prothrombin G20210A among Asian Indian sickle cell patients. Pandey SK; Meena A; Kishor K; Mishra RM; Pandey S; Saxena R Clin Appl Thromb Hemost; 2012 Jun; 18(3):320-3. PubMed ID: 22084413 [TBL] [Abstract][Full Text] [Related]
6. Thrombophilic mutations among Southern Iranian patients with sickle cell disease: high prevalence of factor V Leiden. Rahimi Z; Vaisi-Raygani A; Nagel RL; Muniz A J Thromb Thrombolysis; 2008 Jun; 25(3):288-92. PubMed ID: 17619828 [TBL] [Abstract][Full Text] [Related]
7. Sickle cell anemia, sickle cell beta-thalassemia, and thalassemia major in Albania: characterization of mutations. Boletini E; Svobodova M; Divoky V; Baysal E; Cürük MA; Dimovski AJ; Liang R; Adekile AD; Huisman TH Hum Genet; 1994 Feb; 93(2):182-7. PubMed ID: 8112743 [TBL] [Abstract][Full Text] [Related]
8. Alpha-thalassemia protects against cerebrovascular disease in children with sickle cell anemia. Belisário AR; Martins ML; Velloso-Rodrigues C; Silva CM; Viana MB Arq Neuropsiquiatr; 2012 Aug; 70(8):645. PubMed ID: 22899043 [No Abstract] [Full Text] [Related]
9. MTHFR polymorphic variant C677T is associated to vascular complications in sickle-cell disease. Hatzlhofer BL; Bezerra MA; Santos MN; Albuquerque DM; Freitas EM; Costa FF; Araújo AS; Muniz MT Genet Test Mol Biomarkers; 2012 Sep; 16(9):1038-43. PubMed ID: 22924497 [TBL] [Abstract][Full Text] [Related]
10. Inherited DNA mutations contributing to thrombotic complications in patients with sickle cell disease. Zimmerman SA; Ware RE Am J Hematol; 1998 Dec; 59(4):267-72. PubMed ID: 9840906 [TBL] [Abstract][Full Text] [Related]
11. The Prevalence of Factor V Leiden (G1691A) and Methylenetetrahydrofolate Reductase C677T Mutations in Sickle Cell Disease in Western India. Kangne HK; Jijina FF; Italia YM; Jain DL; Nadkarni AH; Ghosh KK; Colah RB Clin Appl Thromb Hemost; 2015 Mar; 21(2):186-9. PubMed ID: 23869056 [TBL] [Abstract][Full Text] [Related]
13. Genetic predisposition to β-thalassemia and sickle cell anemia in Turkey: a molecular diagnostic approach. Basak AN; Tuzmen S Methods Mol Biol; 2011; 700():291-307. PubMed ID: 21204041 [TBL] [Abstract][Full Text] [Related]
14. Thrombosis-associated gene variants in sickle cell anemia. Romana M; Muralitharan S; Ramasawmy R; Nagel RL; Krishnamoorthy R Thromb Haemost; 2002 Feb; 87(2):356-8. PubMed ID: 11858507 [No Abstract] [Full Text] [Related]
15. Prevalence of thrombotic risk factors among beta-thalassemia patients from Western Iran. Rahimi Z; Ghaderi M; Nagel RL; Muniz A J Thromb Thrombolysis; 2008 Dec; 26(3):229-33. PubMed ID: 17982733 [TBL] [Abstract][Full Text] [Related]
16. Six-year outcome of the national premarital screening and genetic counseling program for sickle cell disease and β-thalassemia in Saudi Arabia. Memish ZA; Saeedi MY Ann Saudi Med; 2011; 31(3):229-35. PubMed ID: 21623050 [TBL] [Abstract][Full Text] [Related]
17. Molecular analysis of beta-thalassemia and sickle cell anemia in Antalya. Keser I; Sanlioglu AD; Manguoglu E; Guzeloglu Kayisli O; Nal N; Sargin F; Yesilipek A; Simsek M; Mendilcioglu I; Canatan D; Luleci G Acta Haematol; 2004; 111(4):205-10. PubMed ID: 15153712 [TBL] [Abstract][Full Text] [Related]